|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 5
Zeitschriftenartikel
Stock, Sophia 
ORCID: https://orcid.org/0000-0002-5072-5013; Klüver, Anna‐Kristina; Fertig, Luisa; Menkhoff, Vivien D.; Subklewe, Marion; Endres, Stefan und Kobold, Sebastian ORCID: https://orcid.org/0000-0002-5612-4673
(2023):
Mechanisms and strategies for safe chimeric antigen receptor T‐cell activity control.
In: International Journal of Cancer, Bd. 153, Nr. 10: S. 1706-1725
[PDF, 4MB]
ORCID: https://orcid.org/0000-0002-5072-5013; Klüver, Anna‐Kristina; Fertig, Luisa; Menkhoff, Vivien D.; Subklewe, Marion; Endres, Stefan und Kobold, Sebastian ORCID: https://orcid.org/0000-0002-5612-4673
(2023):
Mechanisms and strategies for safe chimeric antigen receptor T‐cell activity control.
In: International Journal of Cancer, Bd. 153, Nr. 10: S. 1706-1725
[PDF, 4MB]
Seifert, Matthias; Benmebarek, Mohamed-Reda; Briukhovetska, Daria; Märkl, Florian; Dörr, Janina; Cadilha, Bruno L.; Jobst, Jakob; Stock, Sophia ORCID: https://orcid.org/0000-0002-5072-5013; Andreu-Sanz, David; Lorenzini, Theo; Grünmeier, Ruth ORCID: https://orcid.org/0000-0002-9044-3600; Oner, Arman; Obeck, Hannah; Majed, Lina; Dhoqina, Dario; Feinendegen, Manouk; Gottschlich, Adrian ORCID: https://orcid.org/0000-0002-2898-4182; Zhang, Jin; Schindler, Ulrike; Endres, Stefan ORCID: https://orcid.org/0000-0002-4703-537X und Kobold, Sebastian ORCID: https://orcid.org/0000-0002-5612-4673
(2022):
Impact of the selective A2(A)R and A2(B)R dual antagonist AB928/etrumadenant on CAR T cell function.
In: British Journal of Cancer, Bd. 127, Nr. 12: S. 2175-2185
[PDF, 845kB]
ORCID: https://orcid.org/0000-0002-5072-5013; Andreu-Sanz, David; Lorenzini, Theo; Grünmeier, Ruth ORCID: https://orcid.org/0000-0002-9044-3600; Oner, Arman; Obeck, Hannah; Majed, Lina; Dhoqina, Dario; Feinendegen, Manouk; Gottschlich, Adrian ORCID: https://orcid.org/0000-0002-2898-4182; Zhang, Jin; Schindler, Ulrike; Endres, Stefan ORCID: https://orcid.org/0000-0002-4703-537X und Kobold, Sebastian ORCID: https://orcid.org/0000-0002-5612-4673
(2022):
Impact of the selective A2(A)R and A2(B)R dual antagonist AB928/etrumadenant on CAR T cell function.
In: British Journal of Cancer, Bd. 127, Nr. 12: S. 2175-2185
[PDF, 845kB]
Stock, Sophia ORCID: https://orcid.org/0000-0002-5072-5013; Benmebarek, Mohamed-Reda ORCID: https://orcid.org/0000-0002-1201-7067; Kluever, Anna-Kristina ORCID: https://orcid.org/0000-0001-6246-6082; Darowski, Diana ORCID: https://orcid.org/0000-0002-8778-7920; Jost, Christian ORCID: https://orcid.org/0000-0002-4169-5879; Stubenrauch, Kay-Gunnar; Benz, Joerg; Freimoser-Grundschober, Anne ORCID: https://orcid.org/0000-0001-5715-3639; Moessner, Ekkehard; Umana, Pablo; Subklewe, Marion ORCID: https://orcid.org/0000-0001-9154-9469; Endres, Stefan ORCID: https://orcid.org/0000-0002-4703-537X; Klein, Christian ORCID: https://orcid.org/0000-0001-7594-7280 und Kobold, Sebastian ORCID: https://orcid.org/0000-0002-5612-4673
(2022):
Chimeric antigen receptor T cells engineered to recognize the P329G-mutated Fc part of effector-silenced tumor antigen-targeting human IgG1 antibodies enable modular targeting of solid tumors.
In: Journal for ImmunoTherapy of Cancer, Bd. 10, Nr. 7, e005054
[PDF, 17MB]
ORCID: https://orcid.org/0000-0002-5072-5013; Benmebarek, Mohamed-Reda ORCID: https://orcid.org/0000-0002-1201-7067; Kluever, Anna-Kristina ORCID: https://orcid.org/0000-0001-6246-6082; Darowski, Diana ORCID: https://orcid.org/0000-0002-8778-7920; Jost, Christian ORCID: https://orcid.org/0000-0002-4169-5879; Stubenrauch, Kay-Gunnar; Benz, Joerg; Freimoser-Grundschober, Anne ORCID: https://orcid.org/0000-0001-5715-3639; Moessner, Ekkehard; Umana, Pablo; Subklewe, Marion ORCID: https://orcid.org/0000-0001-9154-9469; Endres, Stefan ORCID: https://orcid.org/0000-0002-4703-537X; Klein, Christian ORCID: https://orcid.org/0000-0001-7594-7280 und Kobold, Sebastian ORCID: https://orcid.org/0000-0002-5612-4673
(2022):
Chimeric antigen receptor T cells engineered to recognize the P329G-mutated Fc part of effector-silenced tumor antigen-targeting human IgG1 antibodies enable modular targeting of solid tumors.
In: Journal for ImmunoTherapy of Cancer, Bd. 10, Nr. 7, e005054
[PDF, 17MB]
Stock, Sophia; Kluever, Anna-Kristina; Endres, Stefan und Kobold, Sebastian
(2022):
Enhanced Chimeric Antigen Receptor T Cell Therapy through Co-Application of Synergistic Combination Partners.
In: Biomedicines, Bd. 10, Nr. 2, 307
Stock, Sophia; Marcon, Julian; Chaloupka, Michael; Becker, Armin; Kunz, Wolfgang G.; Ormanns, Steffen; Pichler, Theresia; Mumm, Friederike H. A.; Holch, Julian W. und Lindner, Lars H.
(2021):
Primary Chemotherapy in a 47-Year-Old Patient with Giant Ulcerative and Necrotizing Nonseminomatous Testicular Germ Cell Tumor.
In: Case Reports in Oncology, Bd. 14, Nr. 1: S. 681-689